Vaxcell-Bio Therapeutics (323990) Ownership - Who Owns Vaxcell-Bio Therapeutics?
Vaxcell-Bio Therapeutics (323990) Ownership Overview
- 2.36% Mutual Funds
- 1.52% ETFs
- 96.12% Public Companies and Individual Investors
The ownership structure of Vaxcell-Bio Therapeutics (KR:323990) stock is a mix of institutional, retail, and individual investors. Approximately 3.88% of the company’s stock is owned by Institutional Investors, and 96.12% is owned by Public Companies and Individual Investors.
The ownership structure of Vaxcell-Bio Therapeutics (KR:323990) stock is a mix of institutional, retail, and individual investors. Approximately 3.88% of the company’s stock is owned by Institutional Investors, and 96.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 343,247 | Institution | 1.48% | 958,689 |
| Vanguard Star Funds | 284,463 | Institution | 1.22% | 794,505 |
| Vanguard Tax-managed Funds | 178,213 | Institution | 0.77% | 497,749 |
| Vanguard International Equity Index Funds | 81,737 | Institution | 0.35% | 228,291 |
| Dimensional | 10,012 | Institution | 0.04% | 27,964 |
| Dfa Investment Dimensions Group Inc | 4,765 | Institution | 0.02% | 13,309 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 284,463 | Institution | 1.22% | 794,505 |
| Vanguard Tax-managed Funds | 178,213 | Institution | 0.77% | 497,749 |
| Vanguard International Equity Index Funds | 81,737 | Institution | 0.35% | 228,291 |
| Dfa Investment Dimensions Group Inc | 4,765 | Institution | 0.02% | 13,309 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 164,813 | Institution | 0.71% | 510,806 |
| Vanguard, VEA ETF | 103,254 | Institution | 0.44% | 320,016 |
| Vanguard, VSS ETF | 29,702 | Institution | 0.13% | 92,056 |
| Vanguard, TSE:VIU ETF | 27,513 | Institution | 0.12% | 107,070 |
| Vanguard, VPL ETF | 13,877 | Institution | 0.06% | 43,009 |
| Dimensional, DFEM ETF | 10,012 | Institution | 0.04% | 28,392 |
| Vanguard, VT ETF | 3,777 | Institution | 0.02% | 11,706 |
| Vanguard, TSE:VA ETF | 311 | Institution | <0.01% | 2,689 |
FAQ
What percentage of Vaxcell-Bio Therapeutics (KR:323990) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.88% of Vaxcell-Bio Therapeutics (KR:323990) stock is held by institutional investors: 2.36% by mutual funds and 1.52% by ETFs.
What percentage of Vaxcell-Bio Therapeutics (KR:323990) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.12% of Vaxcell-Bio Therapeutics (KR:323990) stock is held by public companies and individual investors.
Who owns the most shares of Vaxcell-Bio Therapeutics (KR:323990)?
Vanguard owns the most shares of Vaxcell-Bio Therapeutics (KR:323990).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.